Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+
Industry Domains
Report Overview
The Europe biosimilar market was valued at USD 11.43 Billion in 2025. It is poised to grow at a CAGR of 12.80% during the forecast period of 2026-2035, and reach USD 38.12 Billion by 2035. The market growth benefits from supportive regulatory frameworks led by the European Medicines Agency and cost-containment initiatives accelerating biosimilar adoption. The increasing biologic patent expirations and growing physician confidence in biosimilar safety and efficacy will expand utilization during the forecast period. The rising investments in biosimilar research, manufacturing expansion, and favorable reimbursement incentives will enhance accessibility and sustain robust regional growth.
Key Market Trends and Insights
- By molecule, the insulin glargine segment is projected to lead the market in the forecast period.
- Based on the indication, the autoimmune diseases segment held approximately 39% of the market share in the historical period.
- By manufacturing type, the in-house manufacturing segment is likely to hold a significant share of the forecast period.
Market Size and Forecast
- Market Size (2025): USD 11.43 Billion
- Projected Market Size (2035): USD 38.12 Billion
- CAGR (2026-2035): 12.80%
2025
Base Year
2019-2025
Historical Period
2026-2035
Forecast Period
-
According to the European Commission, approximately 2.7 million new cancer cases were reported across EU Member States in 2024, increasing demand for cost-effective biologics and significantly accelerating market adoption and growth.
-
In February 2026, STADA Arzneimittel AG and Bio-Thera Solutions received European approval for Gotenfia®, a golimumab biosimilar to Simponi®, increasing competition, expanding patient access, and driving cost-efficient biologic adoption, thereby supporting the market value.
-
One of the major market trends includes the launch of denosumab biosimilars to expand treatment access. For instance, in December 2025, Fresenius Kabi launched Conexxence® and Bomyntra® in Europe, improving affordability and accelerating market growth.
Leading Players in the Europe Biosimilar Market
The key features of the market report comprise clinical trials and pipeline analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Sandoz AG
Sandoz AG is a global leader in biosimilars and generics, with a longstanding commitment to expanding access to biologic therapies. The company pioneered biosimilar development in 1996 and has since built a broad portfolio targeting chronic and complex conditions such as autoimmune diseases, diabetes, and oncology. Its biosimilars provide cost-effective alternatives to reference biologics, supporting healthcare system sustainability and patient access. Through continuous innovation, regulatory expertise, and large-scale manufacturing capabilities, the company remains a key participant in the biosimilar market.
Pfizer Inc.
Pfizer Inc. is a global biopharmaceutical leader with a strong presence in biologics and biosimilars, focusing on complex therapies derived from natural systems to treat oncology, immunology, and chronic diseases. The company develops biosimilars designed to match the safety and efficacy of licensed reference biologics through rigorous comparative studies. Its expanding biosimilar portfolio supports broader patient access to advanced treatments while addressing healthcare cost challenges. Pfizer’s ongoing research, manufacturing expertise, and pipeline development reinforce its strategic involvement in the biosimilar market and its commitment to improving treatment accessibility worldwide.
Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. is a leading global pharmaceutical manufacturer with a strong presence in the biosimilar market, supported by more than a century of industry expertise. The company offers a portfolio of nine approved biosimilars and maintains a pipeline exceeding 20 candidates, reflecting its commitment to expanding affordable biologic treatment options. Through its integrated development and manufacturing capabilities, Teva focuses on improving patient access to high-quality therapies while strengthening its competitive position in the evolving biosimilars landscape worldwide.
Celltrion Healthcare
Celltrion Healthcare is a leading global company focused on the commercialization and distribution of biosimilars across autoimmune diseases and oncology. The company has demonstrated strong market involvement through its oncology monoclonal antibody biosimilars, including rituximab, which gained significant adoption following launches in Europe in 2017 and 2018. These products have been widely prescribed across European healthcare systems, reflecting positive clinical acceptance and cost-effectiveness. Celltrion Healthcare’s expanding biosimilar portfolio and early market entry strategy continues to strengthen its position in the biosimilar market.
Other key players in the market are Samsung Bioepis, Amgen Inc., Mylan N?.V., Merck Sharp & Dohme ?Corp., Accord Healthcare ?Ltd., and Boehringer Ingelheim.
Europe Biosimilar Market Report Snapshots
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Looking for specific insights?
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Datasheet
One User
USD 2,699
USD 2,429
tax inclusive*
- Selected Segments
- Printing Restrictions
- Excel Spreadsheet Delivered via Email
- Full Report
- Periodic Updates
- Post Sales Analysts Support
- Unlimited Prints
Single User License
One User
USD 4,299
USD 3,869
tax inclusive*
- All Segments
- Printing Restrictions
- PDF Delivered via Email
- Custom Report Layout
- Post Sales Analysts Support
- Periodic Updates
- Unlimited Prints
Five User License
Five User
USD 5,799
USD 4,949
tax inclusive*
- All Segments
- Five Prints Available
- PDF Delivered via Email
- Limited Free Customization
- Post Sales Analyst Support
- Custom Report Layout
- Periodic Updates
- Unlimited Prints
Corporate License
Unlimited Users
USD 6,999
USD 5,949
tax inclusive*
- All Segments
- Unlimited Prints Available
- PDF & Excel Delivery via Email
- Limited Free Customization
- Post Sales Analysts Support
- Discount On Next Update
- Custom Report Layout
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Bundle Type
Flash Bundle
20% OFF
Number of Reports: 3
Small Business Bundle
25% OFF
Number of Reports: 5
Growth Bundle
30% OFF
Number of Reports: 8
Enterprise Bundle
35% OFF
Number of Reports: 10
Overview
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 80 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 100 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
- 3 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
- Free Analyst Hours
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
- 5 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
- 8 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Free Analyst Hours - 80 Hours
- Power BI Dashboards
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
- 10 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Power BI Dashboards
- Free Analyst Hours - 100 Hours
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.